Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma.
Cancers (Basel). 2021 May 4;13(9):2208. doi: 10.3390/cancers13092208.
Cancers (Basel). 2021.
PMID: 34064450
Free PMC article.
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.
Broqueza J, Prabaharan CB, Allen KJH, Jiao R, Fisher DR, Dickinson R, MacDonald-Dickinson V, Uppalapati M, Dadachova E.
Broqueza J, et al. Among authors: prabaharan cb.
Pharmaceuticals (Basel). 2021 Dec 22;15(1):10. doi: 10.3390/ph15010010.
Pharmaceuticals (Basel). 2021.
PMID: 35056067
Free PMC article.
Item in Clipboard
Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody.
Allen KJH, Kwon O, Hutcheson MR, Grudzinski JJ, Cain SM, Cruz FA, Vinayakamoorthy RM, Sun YS, Fairley L, Prabaharan CB, Dickinson R, MacDonald-Dickinson V, Uppalapati M, Bednarz BP, Dadachova E.
Allen KJH, et al. Among authors: prabaharan cb.
Pharmaceuticals (Basel). 2023 Jul 8;16(7):979. doi: 10.3390/ph16070979.
Pharmaceuticals (Basel). 2023.
PMID: 37513891
Free PMC article.
Item in Clipboard
Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).
Prabaharan CB, Giri S, Allen KJH, Bato KEM, Mercado TR, Malo ME, Carvalho JLC, Dadachova E, Uppalapati M.
Prabaharan CB, et al.
Molecules. 2023 Aug 3;28(15):5839. doi: 10.3390/molecules28155839.
Molecules. 2023.
PMID: 37570809
Free PMC article.
Item in Clipboard
Identifying kinase targets of PPARγ in human breast cancer.
Kandel A, Dhillon SK, Prabaharan CB, Fatnin Binti Hisham S, Rajamanickam K, Napper S, Chidambaram SB, Essa MM, Yang J, Sakharkar MK.
Kandel A, et al. Among authors: prabaharan cb.
J Drug Target. 2021 Jul;29(6):660-668. doi: 10.1080/1061186X.2021.1877719. Epub 2021 Mar 9.
J Drug Target. 2021.
PMID: 33496213
Item in Clipboard
Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer - the role of STAT3 and p21.
Prabaharan CB, Yang AB, Chidambaram D, Rajamanickam K, Napper S, Sakharkar MK.
Prabaharan CB, et al.
Invest New Drugs. 2020 Aug;38(4):909-921. doi: 10.1007/s10637-019-00837-w. Epub 2019 Aug 2.
Invest New Drugs. 2020.
PMID: 31375978
Item in Clipboard
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma.
Giri S, Allen KJH, Prabaharan CB, Ramirez JB, Fiore L, Uppalapati M, Dadachova E.
Giri S, et al. Among authors: prabaharan cb.
Nucl Med Biol. 2024 May 1;134-135:108917. doi: 10.1016/j.nucmedbio.2024.108917. Online ahead of print.
Nucl Med Biol. 2024.
PMID: 38718557
Free article.
Item in Clipboard
Cite
Cite